These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31273064)

  • 1. Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic Cancer.
    Jain A; Agostini LC; McCarthy GA; Chand SN; Ramirez A; Nevler A; Cozzitorto J; Schultz CW; Lowder CY; Smith KM; Waddell ID; Raitses-Gurevich M; Stossel C; Gorman YG; Atias D; Yeo CJ; Winter JM; Olive KP; Golan T; Pishvaian MJ; Ogilvie D; James DI; Jordan AM; Brody JR
    Cancer Res; 2019 Sep; 79(17):4491-4502. PubMed ID: 31273064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranscriptional Regulation of
    Chand SN; Zarei M; Schiewer MJ; Kamath AR; Romeo C; Lal S; Cozzitorto JA; Nevler A; Scolaro L; Londin E; Jiang W; Meisner-Kober N; Pishvaian MJ; Knudsen KE; Yeo CJ; Pascal JM; Winter JM; Brody JR
    Cancer Res; 2017 Sep; 77(18):5011-5025. PubMed ID: 28687616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.
    Brosey CA; Houl JH; Katsonis P; Balapiti-Modarage LPF; Bommagani S; Arvai A; Moiani D; Bacolla A; Link T; Warden LS; Lichtarge O; Jones DE; Ahmed Z; Tainer JA
    Prog Biophys Mol Biol; 2021 Aug; 163():171-186. PubMed ID: 33636189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy.
    Roger E; Gout J; Arnold F; Beutel AK; Müller M; Abaei A; Barth TFE; Rasche V; Seufferlein T; Perkhofer L; Kleger A
    Cells; 2020 Sep; 9(9):. PubMed ID: 32948057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models.
    Coulson-Gilmer C; Morgan RD; Nelson L; Barnes BM; Tighe A; Wardenaar R; Spierings DCJ; Schlecht H; Burghel GJ; Foijer F; Desai S; McGrail JC; Taylor SS
    J Exp Clin Cancer Res; 2021 Oct; 40(1):323. PubMed ID: 34656146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents.
    Matanes E; López-Ozuna VM; Octeau D; Baloch T; Racovitan F; Dhillon AK; Kessous R; Raban O; Kogan L; Salvador S; Lau S; Gotlieb WH; Yasmeen A
    Front Oncol; 2021; 11():745981. PubMed ID: 34778062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells.
    Fathers C; Drayton RM; Solovieva S; Bryant HE
    Cell Cycle; 2012 Mar; 11(5):990-7. PubMed ID: 22333589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death.
    Houl JH; Ye Z; Brosey CA; Balapiti-Modarage LPF; Namjoshi S; Bacolla A; Laverty D; Walker BL; Pourfarjam Y; Warden LS; Babu Chinnam N; Moiani D; Stegeman RA; Chen MK; Hung MC; Nagel ZD; Ellenberger T; Kim IK; Jones DE; Ahmed Z; Tainer JA
    Nat Commun; 2019 Dec; 10(1):5654. PubMed ID: 31827085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of poly(ADP-ribose) glycohydrolase sensitizes lung cancer cells to radiation through the abrogation of DNA damage checkpoint.
    Nakadate Y; Kodera Y; Kitamura Y; Tachibana T; Tamura T; Koizumi F
    Biochem Biophys Res Commun; 2013 Nov; 441(4):793-8. PubMed ID: 24211580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective small molecule inhibition of poly(ADP-ribose) glycohydrolase (PARG).
    Finch KE; Knezevic CE; Nottbohm AC; Partlow KC; Hergenrother PJ
    ACS Chem Biol; 2012 Mar; 7(3):563-70. PubMed ID: 22220926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARG Inhibitors and Functional PARG Inhibition Models.
    Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M
    Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
    Feng X; Koh DW
    Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-Ribose) Glycohydrolase (PARG) Silencing Suppresses Benzo(a)pyrene Induced Cell Transformation.
    Li X; Li X; Zhu Z; Huang P; Zhuang Z; Liu J; Gao W; Liu Y; Huang H
    PLoS One; 2016; 11(3):e0151172. PubMed ID: 27003318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.
    Tanuma SI; Shibui Y; Oyama T; Uchiumi F; Abe H
    Biochem Pharmacol; 2019 Sep; 167():163-172. PubMed ID: 31176615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase.
    Gravells P; Grant E; Smith KM; James DI; Bryant HE
    DNA Repair (Amst); 2017 Apr; 52():81-91. PubMed ID: 28254358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) polymerase inhibition in pancreatic cancer.
    Singh HM; Bailey P; Hübschmann D; Berger AK; Neoptolemos JP; Jäger D; Siveke J; Springfeld C
    Genes Chromosomes Cancer; 2021 May; 60(5):373-384. PubMed ID: 33341987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic activity of poly (ADP-ribose) glycohydrolase.
    Marques M; Jangal M; Wang LC; Kazanets A; da Silva SD; Zhao T; Lovato A; Yu H; Jie S; Del Rincon S; Mackey J; Damaraju S; Alaoui-Jamali M; Witcher M
    Oncogene; 2019 Mar; 38(12):2177-2191. PubMed ID: 30459355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen Receptor and Poly(ADP-ribose) Glycohydrolase Inhibition Increases Efficiency of Androgen Ablation in Prostate Cancer Cells.
    Zhang M; Lai Y; Vasquez JL; James DI; Smith KM; Waddell ID; Ogilvie DJ; Liu Y; Agoulnik IU
    Sci Rep; 2020 Mar; 10(1):3836. PubMed ID: 32123273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADP-ribose).
    Okita N; Ashizawa D; Ohta R; Abe H; Tanuma S
    Biochem Biophys Res Commun; 2010 Feb; 392(4):485-9. PubMed ID: 20079708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of poly(ADP-ribose) glycohydrolase (PARG) in shock, ischemia and reperfusion.
    Cuzzocrea S; Wang ZQ
    Pharmacol Res; 2005 Jul; 52(1):100-8. PubMed ID: 15911338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.